Tsuchiya K - Search Results

1

Neutralization activity of IgG antibody in COVID‑19‑convalescent plasma against SARS-CoV-2 variants.

Tsuchiya K, Maeda K, Matsuda K, Takamatsu Y, Kinoshita N, Kutsuna S, Hayashida T, Gatanaga H, Ohmagari N, Oka S, Mitsuya H. Tsuchiya K, et al. Sci Rep. 2023 Jan 23;13(1):1263. doi: 10.1038/s41598-023-28591-3. Sci Rep. 2023. PMID: 36690803 Free PMC article.

2

Isolation and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replication.

Matsuoka-Aizawa S, Sato H, Hachiya A, Tsuchiya K, Takebe Y, Gatanaga H, Kimura S, Oka S. Matsuoka-Aizawa S, et al. Among authors: tsuchiya k. J Virol. 2003 Jan;77(1):318-27. doi: 10.1128/jvi.77.1.318-327.2003. J Virol. 2003. PMID: 12477837 Free PMC article.

3

"All-in-One Assay", a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug concentrations.

Hachiya A, Matsuoka-Aizawa S, Tsuchiya K, Gatanaga H, Kimura S, Tatsumi M, Oka S. Hachiya A, et al. Among authors: tsuchiya k. J Virol Methods. 2003 Jul;111(1):43-53. doi: 10.1016/s0166-0934(03)00150-2. J Virol Methods. 2003. PMID: 12821196

4

Primary nelfinavir (NFV)-associated resistance mutations during a follow-up period of 108 weeks in protease inhibitor naïve patients treated with NFV-containing regimens in an HIV clinic cohort.

Tsuchiya K, Matsuoka-Aizawa S, Yasuoka A, Kikuchi Y, Tachikawa N, Genka I, Teruya K, Kimura S, Oka S. Tsuchiya K, et al. J Clin Virol. 2003 Aug;27(3):252-62. doi: 10.1016/s1386-6532(02)00179-8. J Clin Virol. 2003. PMID: 12878089

5

Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year.

Bi X, Gatanaga H, Ida S, Tsuchiya K, Matsuoka-Aizawa S, Kimura S, Oka S. Bi X, et al. Among authors: tsuchiya k. J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):1-6. doi: 10.1097/00126334-200309010-00001. J Acquir Immune Defic Syndr. 2003. PMID: 14501787

6

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

Tsuchiya K, Gatanaga H, Tachikawa N, Teruya K, Kikuchi Y, Yoshino M, Kuwahara T, Shirasaka T, Kimura S, Oka S. Tsuchiya K, et al. Biochem Biophys Res Commun. 2004 Jul 9;319(4):1322-6. doi: 10.1016/j.bbrc.2004.05.116. Biochem Biophys Res Commun. 2004. PMID: 15194512

7

Simultaneous determination of six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir), the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.

Hirabayashi Y, Tsuchiya K, Kimura S, Oka S. Hirabayashi Y, et al. Among authors: tsuchiya k. Biomed Chromatogr. 2006 Jan;20(1):28-36. doi: 10.1002/bmc.521. Biomed Chromatogr. 2006. PMID: 15971289

8

Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P450 2B6 *6 and *26.

Gatanaga H, Hayashida T, Tsuchiya K, Yoshino M, Kuwahara T, Tsukada H, Fujimoto K, Sato I, Ueda M, Horiba M, Hamaguchi M, Yamamoto M, Takata N, Kimura A, Koike T, Gejyo F, Matsushita S, Shirasaka T, Kimura S, Oka S. Gatanaga H, et al. Among authors: tsuchiya k. Clin Infect Dis. 2007 Nov 1;45(9):1230-7. doi: 10.1086/522175. Epub 2007 Sep 24. Clin Infect Dis. 2007. PMID: 17918089 Clinical Trial.

9

Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.

Maeda K, Das D, Yin PD, Tsuchiya K, Ogata-Aoki H, Nakata H, Norman RB, Hackney LA, Takaoka Y, Mitsuya H. Maeda K, et al. Among authors: tsuchiya k. J Mol Biol. 2008 Sep 12;381(4):956-74. doi: 10.1016/j.jmb.2008.06.041. Epub 2008 Jun 20. J Mol Biol. 2008. PMID: 18590744 Free PMC article.

10

High-risk status of HIV-1 infection in the very low epidemic country, Mongolia, 2007.

Davaalkham J, Unenchimeg P, Baigalmaa Ch, Oyunbileg B, Tsuchiya K, Hachiya A, Gatanaga H, Nyamkhuu D, Oka S. Davaalkham J, et al. Among authors: tsuchiya k. Int J STD AIDS. 2009 Jun;20(6):391-4. doi: 10.1258/ijsa.2008.008376. Int J STD AIDS. 2009. PMID: 19451323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,976 results

Search Page